Welcome!

News Feed Item

China Jo-Jo Drugstores Announces Fiscal Year 2015 First Quarter Financial Results

HANGZHOU, China, Aug. 12, 2014 /PRNewswire/ -- China Jo-Jo Drugstores, Inc. (NASDAQ CM: CJJD) (the "Company"), a retail and wholesale distributor of pharmaceutical and other healthcare products in the People's Republic of China, today announced earnings results for the quarter ended June 30, 2014.

FY 2015 First Quarter Highlights:

  • Online sales contributed $2.6 million in revenue, an increase of 103.5% from the comparable quarter of prior year
  • Retail sales, which includes online sales, accounted for approximately 80.0% of total revenue, and increased by $2.3 million, or 20.7% year over year to $13.2 million
  • Wholesale, which accounted for approximately 20.0% of total revenue, decreased to $3.3 million from $4.4 million for the same quarter of last year
  • Gross margin decreased quarter over quarter from 23.5% to 15.3%
  • Net loss was $0.35 million compared to $0.79 million for the comparable quarter of prior year; Diluted EPS loss was $0.02 compared to $0.06 for the comparable quarter of prior year

The Company's drugstore sales increased in the first quarter of fiscal 2015, primarily due to a 9.8% increase in same-store sales, and revenues from the proliferation of new stores established over the last few years. Retail profit margin decreased to 17.6% from 25.7% in the first quarter of fiscal 2014 due to strong market competition and the implementation of government subsidies to all drugs sold at public hospitals in Zhejiang Province since April 2014. As of June 30, 2014, we have 49 retail drug stores in total with one new store opened in Hangzhou during the quarter.

The Company's online sales continued to grow dramatically in the first quarter of fiscal 2015, reflecting its efforts in expanding collaboration with large business-to-consumer vendors, better products selection for online consumer, and effective cost control. The Company also plans to implement the O2O (online to offline) drug sales model, which provides deliveries to customers from local stores within a few hours of an online purchase. As online shopping becomes widely used, the Company's sales and technical team gains more experiences in searching for potential customers and satisfying products. The Company's management expects an explosive expansion of its online pharmacy sales in the near future.

Mr. Lei Liu, the Company's Chairman and CEO, stated, "We are glad to see the continued improvement in our retail operation, especially the growth in our same-store sales and online store. Wholesale business declined in the first quarter as we have been undergoing restructure of the division in the past few quarters, including a change in sales and management team of wholesale division."

"For the remaining of fiscal 2015," Concluded by Mr. Liu, "we anticipate to grow revenue primarily through our retail operations and online pharmacy while stabilizing our wholesale operations with an eye to achieve bottom line results."

Forward Looking Statement

Statements in this press release regarding the Company that are not historical facts are forward-looking statements and are subject to risks and uncertainties that could cause actual future events or results to differ materially from such statements. Any such forward-looking statements, including, but not limited to, financial guidance, are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. These statements can be identified by the use of forward-looking terminology such as "believe," "expect," "may," "will," "should," "project," "plan," "seek," "intend," "anticipate," the negatives thereof, or comparable terminology. Such statements typically involve risks and uncertainties and may include financial projections or information regarding the progress of new product development. It is routine for the Company's internal projections and expectations to change as the quarter and year progresses, and therefore it should be clearly understood that the internal projections and beliefs upon which the Company bases its expectations may change. Although these expectations may change, the Company is under no obligation to inform you if they do. Actual results could differ materially from the expectations reflected in such forward-looking statements as a result of numerous factors, including the risks associated with the effect of changing economic conditions in the People's Republic of China, variations in cash flow, reliance on collaborative retail partners and on new product development, variations in new product development, risks associated with rapid technological change, and the potential of introduced or undetected flaws and defects in products. Readers are referred to the reports and documents filed from time to time by the Company with the Securities and Exchange Commission for a discussion of these and other important risk factors that could cause actual results to differ from those discussed in forward-looking statements. The Company also routinely posts important information on its corporate websites, which readers can access at www.jiuzhou-drugstore.com  (Chinese) and www.chinajojodrugstores.com  (English).

See Accompanying Tables

 

 

CHINA JO-JO DRUGSTORES, INC AND SUBSIDIARIES

CONDENSED CONSOLIDATED BALANCE SHEETS

(UNAUDITED)

 



June 30,



March 31,




2014



2014


A S S E T S







CURRENT ASSETS







Cash


$

3,378,916



$

4,445,276


Restricted cash



3,706,658




3,114,543


Trade accounts receivable, net



5,677,129




6,734,536


Inventories



7,223,808




8,419,132


Other receivables, net



425,983




149,546


Advances to suppliers, net



3,184,527




4,577,194


Other current assets



1,726,872




1,663,102


Total current assets



25,323,893




29,103,329











PROPERTY AND EQUIPMENT, net



9,034,288




9,412,688











OTHER ASSETS









Long-term biological assets



1,373,425




-


Long term deposits



2,764,792




2,786,437


Other noncurrent assets



2,947,235




3,036,930


Intangible assets, net



1,563,347




1,569,443


Total other assets



8,648,799




7,392,810











Total assets


$

43,006,980



$

45,908,827











L I A B I L I T I E S A N D S T O C K H O L D E R S' E Q U I T Y









CURRENT LIABILITIES









Short-term loan payable


$

-



$

162,300


Accounts payable, trade



10,218,415




14,554,726


Notes payable



9,065,063




7,820,718


Other payables



1,825,591




1,282,211


Other payables - related parties



2,808,588




2,384,294


Loan from third parties



234,813




294,042


Customer deposits



3,386,007




3,185,885


Taxes payable



349,562




373,501


Accrued liabilities



823,309




1,208,242


Total current liabilities



28,711,348




31,265,919











Purchase option and warrant liability



155,217




278,916


Total liabilities



28,866,565




31,544,835











COMMITMENTS AND CONTINGENCIES


















STOCKHOLDERS' EQUITY









Preferred stock; $0.001 par value; 10,000,000 shares authorized; nil issued and
   outstanding as of March 31, 2014 and June 30, 2014                                                       



-




-


Common stock; $0.001 par value; 250,000,000 shares authorized; 14,416,022 and    14,416,022 shares issued and outstanding as of June 30, 2014 and March 31, 2014



14,416




14,416


Additional paid-in capital



17,427,911




17,355,555


Statutory reserves



1,309,109




1,309,109


Accumulated deficit



(8,607,504)




(8,260,767)


Accumulated other comprehensive income



3,957,404




3,905,136


Total stockholders' equity



14,101,336




14,323,449











Noncontrolling interests



39,079




40,543


Total equity



14,140,415




14,363,992











Total liabilities and stockholders' equity


$

43,006,980



$

45,908,827


 

 

 

CHINA JO-JO DRUGSTORES, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS

(UNAUDITED)

 



For the three months ended
June 30,




2014



2013


REVENUES, NET


$

16,459,232



$

15,336,519











COST OF GOODS SOLD



13,948,613




11,735,350











GROSS PROFIT



2,510,619




3,601,169











SELLING EXPENSES



1,768,577




1,680,842


GENERAL AND ADMINISTRATIVE EXPENSES



1,081,201




2,640,818


TOTAL OPERATING EXPENSES



2,849,778




4,321,660











LOSS FROM OPERATIONS



(339,159)




(720,491)











OTHER LOSS, NET



(115,836)




(40,413)


CHANGE IN FAIR VALUE OF DERIVATIVE LIABILITIES



123,699




12,665











LOSS BEFORE INCOME TAXES



(331,296)




(748,239)











PROVISION FOR INCOME TAXES



16,141




39,520











NET LOSS



(347,437)




(787,759)











ADD: NET LOSS ATTRIBUTABLE TO NONCONTROLLING INTEREST  



700




243











NET LOSS ATTRIBUTABLE TO CHINA JO-JO DRUGSTORES, INC.



(346,737)




(787,516)











OTHER COMPREHENSIVE INCOME









Foreign currency translation adjustments                                                           



52,268




759,791











COMPREHENSIVE LOSS


$

(294,469)



$

(27,725)











WEIGHTED AVERAGE NUMBER OF SHARES:









Basic



14,416,022




13,609,003


Diluted



14,416,022




13,609,003











LOSSES PER SHARES:









Basic


$

(0.02)



$

(0.06)


Diluted


$

(0.02)



$

(0.06)


 

 

 

CHINA JO-JO DRUGSTORES, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(UNAUDITED)

 



Three months ended
June 30,




2014



2013


CASH FLOWS FROM OPERATING ACTIVITIES:







Net loss


$

(347,437)



$

(787,759)


Adjustments to reconcile net (loss) income to net cash provided by (used in) operating   activities:









Depreciation and amortization



502,101




588,936


Stock compensation



71,544




27,338


Bad debt provision



(637,819)




1,181,478


Inventory reserve



4,316




-


Change in fair value of purchase option derivative liability                                                  



(123,699)




(12,665)


Change in operating assets:









Accounts receivable, trade



1,187,128




(190,989)


Notes receivable



-




(290,214)


Inventories and biological assets



(171,784)




(398,271)


Other receivables



(59,183)




(159,171)


Advances to suppliers



1,694,269




(1,111,259)


Other current assets



(61,633)




(782,304)


Long term deposit



25,040




-


Other noncurrent assets



93,294




49,586


Change in operating liabilities:









Accounts payable, trade



(4,347,548)




1,363,429


Other payables and accrued liabilities



155,208




(570,952)


Customer deposits



195,894




365,295


Taxes payable



(24,361)




(2,212)


Net cash used in operating activities



(1,844,670)




(729,734)











CASH FLOWS FROM INVESTING ACTIVITIES:









Purchase of equipment



(104,682)




(2,934)


Additions to leasehold improvements



-




(3,958)


Payments on construction-in-progress



-




(111,152)


Net cash used in investing activities



(104,682)




(118,044)











CASH FLOWS FROM FINANCING ACTIVITIES:









Proceeds from short-term bank loan



-




161,230


Repayment of short-term bank loan



(162,250)




-


Repayment of  third parties loan



(59,500)




-


Change in restricted cash



(587,371)




(1,336,189)


Proceeds from notes payable



1,918,599




650,108


Repayments of notes payable



(685,791)




(816,304)


Proceeds from other payables-related parties



423,752




194,973


Net cash provided by financing activities



847,439




(1,146,182)











EFFECT OF EXCHANGE RATE ON CASH



35,553




181,265











DECREASE IN CASH



(1,066,360)




(1,812,695)











CASH, beginning of period



4,445,276




4,524,094











CASH, end of period


$

3,378,916



$

2,711,399




















SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION:









Cash paid for income taxes


$

21,325



$

9,529


Cash paid for interest


$

1,460



$

8,764


 

 

SOURCE China Jo-Jo Drugstores

More Stories By PR Newswire

Copyright © 2007 PR Newswire. All rights reserved. Republication or redistribution of PRNewswire content is expressly prohibited without the prior written consent of PRNewswire. PRNewswire shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.

Latest Stories
In his Opening Keynote at 21st Cloud Expo, John Considine, General Manager of IBM Cloud Infrastructure, led attendees through the exciting evolution of the cloud. He looked at this major disruption from the perspective of technology, business models, and what this means for enterprises of all sizes. John Considine is General Manager of Cloud Infrastructure Services at IBM. In that role he is responsible for leading IBM’s public cloud infrastructure including strategy, development, and offering m...
Sanjeev Sharma Joins June 5-7, 2018 @DevOpsSummit at @Cloud Expo New York Faculty. Sanjeev Sharma is an internationally known DevOps and Cloud Transformation thought leader, technology executive, and author. Sanjeev's industry experience includes tenures as CTO, Technical Sales leader, and Cloud Architect leader. As an IBM Distinguished Engineer, Sanjeev is recognized at the highest levels of IBM's core of technical leaders.
Product connectivity goes hand and hand these days with increased use of personal data. New IoT devices are becoming more personalized than ever before. In his session at 22nd Cloud Expo | DXWorld Expo, Nicolas Fierro, CEO of MIMIR Blockchain Solutions, will discuss how in order to protect your data and privacy, IoT applications need to embrace Blockchain technology for a new level of product security never before seen - or needed.
The 22nd International Cloud Expo | 1st DXWorld Expo has announced that its Call for Papers is open. Cloud Expo | DXWorld Expo, to be held June 5-7, 2018, at the Javits Center in New York, NY, brings together Cloud Computing, Digital Transformation, Big Data, Internet of Things, DevOps, Machine Learning and WebRTC to one location. With cloud computing driving a higher percentage of enterprise IT budgets every year, it becomes increasingly important to plant your flag in this fast-expanding busin...
Digital transformation is about embracing digital technologies into a company's culture to better connect with its customers, automate processes, create better tools, enter new markets, etc. Such a transformation requires continuous orchestration across teams and an environment based on open collaboration and daily experiments. In his session at 21st Cloud Expo, Alex Casalboni, Technical (Cloud) Evangelist at Cloud Academy, explored and discussed the most urgent unsolved challenges to achieve f...
SYS-CON Events announced today that Synametrics Technologies will exhibit at SYS-CON's 22nd International Cloud Expo®, which will take place on June 5-7, 2018, at the Javits Center in New York, NY. Synametrics Technologies is a privately held company based in Plainsboro, New Jersey that has been providing solutions for the developer community since 1997. Based on the success of its initial product offerings such as WinSQL, Xeams, SynaMan and Syncrify, Synametrics continues to create and hone inn...
Digital Transformation (DX) is not a "one-size-fits all" strategy. Each organization needs to develop its own unique, long-term DX plan. It must do so by realizing that we now live in a data-driven age, and that technologies such as Cloud Computing, Big Data, the IoT, Cognitive Computing, and Blockchain are only tools. In her general session at 21st Cloud Expo, Rebecca Wanta explained how the strategy must focus on DX and include a commitment from top management to create great IT jobs, monitor ...
In a recent survey, Sumo Logic surveyed 1,500 customers who employ cloud services such as Amazon Web Services (AWS), Microsoft Azure, and Google Cloud Platform (GCP). According to the survey, a quarter of the respondents have already deployed Docker containers and nearly as many (23 percent) are employing the AWS Lambda serverless computing framework. It’s clear: serverless is here to stay. The adoption does come with some needed changes, within both application development and operations. Tha...
Cloud Expo | DXWorld Expo have announced the conference tracks for Cloud Expo 2018. Cloud Expo will be held June 5-7, 2018, at the Javits Center in New York City, and November 6-8, 2018, at the Santa Clara Convention Center, Santa Clara, CA. Digital Transformation (DX) is a major focus with the introduction of DX Expo within the program. Successful transformation requires a laser focus on being data-driven and on using all the tools available that enable transformation if they plan to survive ov...
A strange thing is happening along the way to the Internet of Things, namely far too many devices to work with and manage. It has become clear that we'll need much higher efficiency user experiences that can allow us to more easily and scalably work with the thousands of devices that will soon be in each of our lives. Enter the conversational interface revolution, combining bots we can literally talk with, gesture to, and even direct with our thoughts, with embedded artificial intelligence, whic...
You know you need the cloud, but you're hesitant to simply dump everything at Amazon since you know that not all workloads are suitable for cloud. You know that you want the kind of ease of use and scalability that you get with public cloud, but your applications are architected in a way that makes the public cloud a non-starter. You're looking at private cloud solutions based on hyperconverged infrastructure, but you're concerned with the limits inherent in those technologies. What do you do?
Recently, REAN Cloud built a digital concierge for a North Carolina hospital that had observed that most patient call button questions were repetitive. In addition, the paper-based process used to measure patient health metrics was laborious, not in real-time and sometimes error-prone. In their session at 21st Cloud Expo, Sean Finnerty, Executive Director, Practice Lead, Health Care & Life Science at REAN Cloud, and Dr. S.P.T. Krishnan, Principal Architect at REAN Cloud, discussed how they built...
Recently, WebRTC has a lot of eyes from market. The use cases of WebRTC are expanding - video chat, online education, online health care etc. Not only for human-to-human communication, but also IoT use cases such as machine to human use cases can be seen recently. One of the typical use-case is remote camera monitoring. With WebRTC, people can have interoperability and flexibility for deploying monitoring service. However, the benefit of WebRTC for IoT is not only its convenience and interopera...
In his general session at 21st Cloud Expo, Greg Dumas, Calligo’s Vice President and G.M. of US operations, discussed the new Global Data Protection Regulation and how Calligo can help business stay compliant in digitally globalized world. Greg Dumas is Calligo's Vice President and G.M. of US operations. Calligo is an established service provider that provides an innovative platform for trusted cloud solutions. Calligo’s customers are typically most concerned about GDPR compliance, application p...
Modern software design has fundamentally changed how we manage applications, causing many to turn to containers as the new virtual machine for resource management. As container adoption grows beyond stateless applications to stateful workloads, the need for persistent storage is foundational - something customers routinely cite as a top pain point. In his session at @DevOpsSummit at 21st Cloud Expo, Bill Borsari, Head of Systems Engineering at Datera, explored how organizations can reap the bene...